Announcements Trials
Browse Landscape

Phase

Phase 2 107Phase 1/2 7Phase 1 7Phase NA 6Phase 2/3 6Phase 3 5Phase EARLY_PHASE1 2

Status

Recruiting 15Completed 7Not yet recruiting 6Unknown 5Active not recruiting 3

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Radiation Pneumonitis 1Nasopharyngeal Neoplasms 1HER2+ Breast Cancer 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Cisplatin 129Radiotherapy 94Carboplatin 82Fluorouracil 77Paclitaxel 76Cyclophosphamide 76Gemcitabine 71Capecitabine 66Docetaxel 64Doxorubicin 59Oxaliplatin 57Etoposide 57Leucovorin 48Vincristine 46Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 23Methotrexate 21Rituximab 19Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Unknown × sintilimab × Clear all
NCT06161909 2023-12-08

Postoperative Immune Maintenance Therapy for Esophageal Squamous Cell Carcinoma After Radical Resection

Fujian Medical University Union Hospital

Phase 3 Unknown
400 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT06031597 2023-09-13

Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy

Zhejiang Cancer Hospital

Phase 3 Unknown
105 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Radiation Pneumonitis

NCT03700476 2023-03-28

CONTINUUM

Sun Yat-sen University

Phase 3 Unknown
425 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT05648071 2022-12-13

SPBPDC

Qianfoshan Hospital

Phase 3 Unknown
60 enrolled
Thoracic

Advanced Non-squamous Non-Small-Cell Lung Cancer

NCT05429684 2022-06-23

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

First Affiliated Hospital Xi'an Jiaotong University

Phase 3 Unknown
120 enrolled
Breast

HER2+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡